AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 157 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | +200.0% | 573 | +48.4% | 0.00% | – |
| Q2 2023 | $1 | 0.0% | 386 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | -99.5% | 386 | -99.6% | 0.00% | -100.0% |
| Q4 2022 | $195 | -99.9% | 97,810 | -0.2% | 0.01% | -10.0% |
| Q3 2022 | $198,000 | -36.5% | 97,970 | -0.3% | 0.01% | -28.6% |
| Q2 2022 | $312,000 | -49.4% | 98,236 | -33.4% | 0.01% | -41.7% |
| Q1 2022 | $616,000 | +13.4% | 147,518 | +30.0% | 0.02% | +41.2% |
| Q4 2021 | $543,000 | -13.3% | 113,439 | -3.3% | 0.02% | -15.0% |
| Q3 2021 | $626,000 | +2.0% | 117,255 | -2.4% | 0.02% | 0.0% |
| Q2 2021 | $614,000 | -24.0% | 120,182 | +0.1% | 0.02% | -31.0% |
| Q1 2021 | $808,000 | +16060.0% | 120,020 | +10264.4% | 0.03% | – |
| Q4 2020 | $5,000 | +25.0% | 1,158 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -33.3% | 1,158 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | – | 1,158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $90,819,890 | 14.58% |
| Eversept Partners, LP | 2,644,988 | $11,161,849 | 0.94% |
| TPG GP A, LLC | 12,328,767 | $52,027,397 | 0.90% |
| Nantahala Capital Management | 2,212,757 | $9,337,835 | 0.80% |
| Rubric Capital Management LP | 4,024,500 | $16,983,390 | 0.64% |
| Hedges Asset Management LLC | 84,600 | $357,012 | 0.31% |
| Signature Wealth Management Partners, LLC | 66,666 | $281,331 | 0.28% |
| Tejara Capital Ltd | 96,672 | $407,956 | 0.23% |
| Tranquilli Financial Advisor LLC | 71,414 | $301,367 | 0.22% |
| EAM Investors, LLC | 230,271 | $971,744 | 0.19% |